Want to see IN:MEDANTA full AI Analyst Report?
Global Health Limited (MEDANTA) Ratios
Global Health Limited Ratios
IN:MEDANTA's free cash flow for Q1 2027 was $0.00. For the 2027 fiscal year, IN:MEDANTA's free cash flow was increased by $0.00 and operating cash flow was $0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.67 | 2.48 | 2.44 | 2.76 | 1.94 |
| Quick Ratio | 2.54 | 2.37 | 2.33 | 2.65 | 1.80 |
| Cash Ratio | 0.20 | 0.37 | 0.69 | 1.34 | 0.28 |
| Solvency Ratio | 0.41 | 0.49 | 0.47 | 0.28 | 0.21 |
| Operating Cash Flow Ratio | 1.20 | 1.01 | 0.99 | 1.13 | 0.74 |
| Short-Term Operating Cash Flow Coverage | 25.14 | 9.78 | 4.50 | 6.13 | 4.43 |
| Net Current Asset Value | $ -2.46B | $ 1.54B | $ 1.10B | $ -1.08B | $ -7.18B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.20 | 0.15 | 0.19 | 0.27 | 0.35 |
| Debt-to-Equity Ratio | 0.30 | 0.21 | 0.28 | 0.46 | 0.69 |
| Debt-to-Capital Ratio | 0.23 | 0.17 | 0.22 | 0.32 | 0.41 |
| Long-Term Debt-to-Capital Ratio | 0.13 | 0.07 | 0.09 | 0.23 | 0.32 |
| Financial Leverage Ratio | 1.49 | 1.41 | 1.48 | 1.70 | 1.95 |
| Debt Service Coverage Ratio | 7.85 | 5.78 | 3.48 | 3.03 | 2.71 |
| Interest Coverage Ratio | 8.80 | 11.51 | 16.27 | 6.32 | 4.16 |
| Debt to Market Cap | 0.02 | 0.01 | 0.01 | 0.06 | 0.08 |
| Interest Debt Per Share | 47.23 | 29.10 | 32.53 | 46.29 | 47.06 |
| Net Debt to EBITDA | 1.05 | 0.54 | 0.43 | 0.52 | 2.02 |
| Profitability Margins | |||||
| Gross Profit Margin | 47.50% | 75.81% | 52.42% | 76.79% | 74.95% |
| EBIT Margin | 18.01% | 19.56% | 21.36% | 19.55% | 16.61% |
| EBITDA Margin | 23.05% | 24.89% | 26.62% | 25.17% | 22.60% |
| Operating Profit Margin | 15.79% | 20.26% | 35.75% | 18.27% | 15.26% |
| Pretax Profit Margin | 16.21% | 17.80% | 19.15% | 16.68% | 12.95% |
| Net Profit Margin | 12.62% | 13.24% | 14.60% | 12.10% | 9.05% |
| Continuous Operations Profit Margin | 12.56% | 13.24% | 14.60% | 12.10% | 9.05% |
| Net Income Per EBT | 77.82% | 74.38% | 76.25% | 72.58% | 69.93% |
| EBT Per EBIT | 102.65% | 87.85% | 53.55% | 91.26% | 84.83% |
| Return on Assets (ROA) | 9.42% | 10.10% | 11.11% | 7.92% | 6.24% |
| Return on Equity (ROE) | 14.05% | 14.22% | 16.46% | 13.43% | 12.14% |
| Return on Capital Employed (ROCE) | 13.20% | 17.76% | 31.77% | 13.89% | 12.13% |
| Return on Invested Capital (ROIC) | 10.11% | 12.92% | 23.14% | 9.70% | 8.17% |
| Return on Tangible Assets | 9.45% | 10.12% | 11.12% | 7.93% | 6.25% |
| Earnings Yield | 2.15% | 1.46% | 1.34% | 2.39% | 1.87% |
| Efficiency Ratios | |||||
| Receivables Turnover | 10.73 | 12.46 | 13.87 | 12.06 | 9.81 |
| Payables Turnover | 9.55 | 4.52 | 8.34 | 10.38 | 4.04 |
| Inventory Turnover | 29.32 | 13.10 | 23.31 | 10.36 | 9.78 |
| Fixed Asset Turnover | 1.13 | 1.20 | 1.25 | 1.14 | 0.98 |
| Asset Turnover | 0.75 | 0.76 | 0.76 | 0.65 | 0.69 |
| Working Capital Turnover Ratio | 4.50 | 4.03 | 3.45 | 3.85 | 8.85 |
| Cash Conversion Cycle | 8.27 | -23.68 | -1.77 | 30.35 | -15.78 |
| Days of Sales Outstanding | 34.03 | 29.29 | 26.31 | 30.27 | 37.20 |
| Days of Inventory Outstanding | 12.45 | 27.86 | 15.66 | 35.24 | 37.33 |
| Days of Payables Outstanding | 38.21 | 80.83 | 43.75 | 35.15 | 90.31 |
| Operating Cycle | 46.48 | 57.15 | 41.97 | 65.51 | 74.53 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 28.03 | 23.22 | 22.79 | 24.86 | 12.33 |
| Free Cash Flow Per Share | -8.39 | 3.99 | 12.42 | 15.76 | 1.46 |
| Dividend Paid and CapEx Coverage Ratio | 0.76 | 1.21 | 2.20 | 2.73 | 1.13 |
| Capital Expenditure Coverage Ratio | 0.77 | 1.21 | 2.20 | 2.73 | 1.13 |
| Operating Cash Flow Coverage Ratio | 0.63 | 0.87 | 0.76 | 0.57 | 0.28 |
| Operating Cash Flow to Sales Ratio | 0.17 | 0.17 | 0.19 | 0.24 | 0.14 |
| Free Cash Flow Yield | -0.87% | 0.32% | 0.93% | 2.99% | 0.35% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 46.41 | 68.70 | 74.78 | 41.89 | 53.45 |
| Price-to-Sales (P/S) Ratio | 5.86 | 9.09 | 10.92 | 5.07 | 4.84 |
| Price-to-Book (P/B) Ratio | 6.52 | 9.77 | 12.31 | 5.63 | 6.49 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -114.57 | 308.49 | 107.22 | 33.43 | 285.06 |
| Price-to-Operating Cash Flow Ratio | 34.29 | 53.02 | 58.42 | 21.19 | 33.69 |
| Price-to-Earnings Growth (PEG) Ratio | 2.98 | 101.90 | 1.80 | 0.68 | 0.09 |
| Enterprise Value Multiple | 26.45 | 37.08 | 41.45 | 20.67 | 23.43 |
| Enterprise Value | 268.87B | 335.62B | 361.36B | 140.14B | 114.76B |
| EV to EBITDA | 26.45 | 37.08 | 41.45 | 20.67 | 23.43 |
| EV to Sales | 6.10 | 9.23 | 11.03 | 5.20 | 5.30 |
| EV to Free Cash Flow | -119.28 | 313.04 | 108.35 | 34.30 | 311.96 |
| EV to Operating Cash Flow | 35.70 | 53.81 | 59.04 | 21.74 | 36.87 |
| Tangible Book Value Per Share | 147.68 | 125.67 | 107.97 | 93.48 | 63.75 |
| Shareholders’ Equity Per Share | 147.44 | 126.05 | 108.17 | 93.68 | 64.00 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.23 | 0.26 | 0.24 | 0.27 | 0.30 |
| Revenue Per Share | 164.14 | 135.36 | 121.93 | 103.94 | 85.83 |
| Net Income Per Share | 20.71 | 17.92 | 17.80 | 12.58 | 7.77 |
| Tax Burden | 0.78 | 0.74 | 0.76 | 0.73 | 0.70 |
| Interest Burden | 0.90 | 0.91 | 0.90 | 0.85 | 0.78 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.32 | 0.18 | 0.15 | 0.15 | 0.11 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.35 | 1.30 | 1.28 | 1.43 | 1.11 |
Currency in INR